aryogen.com
Contattaci
Circa la società
The Ariogen Pharmaceutical Biotechnology Research Center started its activity in October 2012 following the approval of the Council for the Development of Medical Sciences Universities, with the aim of strengthening and expanding the infrastructure needed for the production of recombinant drugs. The center aims to collaborate with academia and internationally renowned universities and institutes, while improving the country's contribution to the production and transfer of knowledge in the field of pharmaceutical biotechnology.
IR
Sconosciuto
Azienda non verificata
Trasparenza aziendale
- Informazioni sull'azienda non verificate
- Chiedi ai loro clienti per le recensioni
- Non ha risposto alle recensioni negative